Miscellaneous

CenterWatch Monthly February 2008 Issue

Friday, February 15, 2008 03:22 PM

Site Training on EDC Improves

More... »

CWWeekly February 11th 2008 Issue

Friday, February 15, 2008 12:32 PM

Top News

More... »

Ketek Hearing Winners and Losers

Wednesday, February 13, 2008 04:09 PM

After listening to the Feb. 12th hearing by the House Energy and Commerce’s Subcommittee on Oversight and Investigations probing study fraud and the antibiotic Ketek, one thing is clear: PPD, which monitored the study in question sponsored by Aventis (now Sanofi-Aventis), took the least hits from Congress. And it is also quite clear that many in Congress, including committee staff, don’t seem to understand much about the research process.

More... »

Trial Results for Psoriasis Drug Ustekinumab Hit Mark

Wednesday, February 13, 2008 02:15 PM

Centocor reported one year data from a phase III trial of ustekinumab (CNTO-1275), a monoclonal antibody against the p40 subunit of IL-12 and IL-23 for the treatment of moderate to severe plaque psoriasis. This randomized, double-blind, placebo-controlled trial, dubbed PHOENIX-1, enrolled 766 subjects.

More... »

Revolutionary Public-Private Partnership for Early Phase Trials Established in France

Tuesday, February 12, 2008 01:09 PM

The Centre Hospitalier Universitaire (CHU) de Caen, a university teaching hospital and the largest hospital in the West of France, and Therapharm, a large, private contract research organization founded in 1980, have joined forces to form the first public-private partnership to conduct early phase clinical research in France. The clinical research center is called Centre de Recherche Clinique-Basse Normandie (CRC-BN). The center conducts phase I and II clinical trials that are industry-sponsored, investigator-initiated and government-sponsored.

More... »

Veritas Medicine Restructures Business, Drops Trial Listing Service

Monday, February 11, 2008 11:28 AM

Cambridge, Mass.-based Veritas Medicine, a clinical trial services company, has discontinued its patient recruitment services and laid off a number of employees.

More... »

CWWeekly Feb. 4th 2008 Issue

Friday, February 8, 2008 02:22 PM

Top News

More... »

Covance Reports Jump in Fourth Quarter Revenue

Friday, February 8, 2008 01:55 PM

Princeton, N.J.-based CRO Covance reported a nearly 20% jump in fourth quarter net revenue to $411 million compared with $343 million in 2006. Net income was also impressive, $47 million, a 22% increase compared with the fourth quarter of 2006. Earnings per share were $0.72 in the quarter, up 21.8% compared with the fourth quarter of 2006. Fourth quarter revenues were split evenly between Covance’s early development and late-stage development business units.

More... »

Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report

Wednesday, February 6, 2008 11:56 AM

BOSTON, Feb. 6 -- CenterWatch, a publishing and information services company focused on market research about clinical trials, finds in a new report that the Asia-Pacific region is grabbing an increasing share of the global clinical trial market, and with new regulatory changes across the region, has already been growing at more than 50% in recent years.

More... »

Rituximab Hits Endpoints for New Indication

Tuesday, February 5, 2008 09:54 AM

Roche issued positive results from a phase III trial of MabThera (Rituxan, rituximab) as a first-line therapy for rheumatoid arthritis. This international, randomized, placebo controlled, double blind, parallel group study was dubbed SERENE (Study Evaluating Rituximab’s Efficacy in methotrexate iNadequate rEsponders).

More... »